CCAM
AMGN icon

Cascades Capital Asset Management’s Amgen AMGN Stock Holding History

Cascades Capital Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777K Hold
2,146
– – 0.29% 63
2026
Q1 		$755K Hold
2,146
– – 0.32% 60
2025
Q4 		$702K Buy
2,146
+8
+0.4% +$2.54K 0.29% 61
2025
Q3 		$603K Sell
2,138
-41
-2% -$11.9K 0.27% 65
2025
Q2 		$608K Buy
2,179
+65
+3% +$18.4K 0.31% 55
2025
Q1 		$659K Hold
2,114
– – 0.36% 49
2024
Q4 		$551K Hold
2,114
– – 0.29% 56
2024
Q3 		$681K Buy
+2,114
New +$692K 0.38% 47

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cascades Capital Asset Management's AMGN Position: Q2 2026 in Review

Cascades Capital Asset Management held its Amgen (AMGN) position steady in Q2 2026 at 2,146 shares worth $777K. The position accounts for 0.29% of the portfolio, ranked #63.

Cascades Capital Asset Management first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cascades Capital Asset Management held 2,146 shares of Amgen worth $777K as of Q2 2026.
  • Cascades Capital Asset Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.29% of Cascades Capital Asset Management's portfolio in Q2 2026, its #63 holding.
  • Cascades Capital Asset Management first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cascades Capital Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.